However, the clinical outcome of patients with CK was not affected by the presence of HR-FISH, suggesting that other clinicobiological features than TP53 status may also contribute to the poor prognosis of CLL with CK. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.